Master's Thesis
Surface modification of mesenchymal stromal cell-derived extracellular vesicles with peptides for targeted cancer therapy
— 2022
Key information
Authors:
Supervisors:
Published in
November 16, 2022
Abstract
Conventional systemic cancer therapies induce severe side effects. This limits the efficacy of current therapeutic strategies and this challenge needs to be addressed by novel approaches. In the last decade, extracellular vesicles (EVs), phospholipid bilayer membrane structures released by all cells, emerged as promising nano drug delivery systems (NDDS). These display amenability for loading with multiple anticancer therapeutics and engineering aimed to improve their accumulation at the target tissues. In order to develop an EV-based NDDS for targeted cancer therapy, in this work, EVs derived from mesenchymal stromal cells and MDA-MB-231 derived EVs were isolated through a scalable and selective protocol comprising tangential flow filtration (TFF) and size exclusion chromatography (SEC). Here, the adjustment of upstream and downstream processing such as the cell confluence reached during expansion as well as the MWCO of amicons used for the EV ultrafiltration, were identified to be crucial parameters for increased batch yields. Moreover, EVs were decorated with a targeting moiety that includes p28, a peptide that displays preferential penetration into cancer cells. The anchoring to EVs was achieved through the use of a novel fusion peptide combining p28 with CP05, which anchors itself in the surface of EVs by interacting with CD63. Incubation of breast cancer cells with EVs-p28 led to increased cell uptake of EVs by 1,4-fold, showing their superiority as a NDDS. Future work targeting the evaluation of the drug delivery efficiency of this system is important as it will allow greater understanding of the potential application of the proposed NDDS.
Publication details
Authors in the community:
Supervisors of this institution:
Cláudia Lobato da Silva
ist31519
Nuno Bernardes
ist153406
Fields of Science and Technology (FOS)
industrial-biotechnology - Industrial Biotechnology
Publication language (ISO code)
eng - English
Rights type:
Embargo lifted
Date available:
August 26, 2023
Institution name
Instituto Superior Técnico